



Version of attached le:
Published Version
Peer-review status of attached le:
Peer-reviewed
Citation for published item:
Baumann, Marcus and Bracken, Cormac and *Batsanov, Andrei S. (2021) 'Development of a Continuous
Photochemical Benzyne-Forming Process.', SynOpen, 05 (01). pp. 29-35.
Further information on publisher's website:
https://doi.org/10.1055/s-0040-1706016
Publisher's copyright statement:
Open Access. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0),




The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-prot purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
https://dro.dur.ac.uk
29
© 2021. The Author(s). SynOpen 2021, 5, 29–35
Georg Thieme Verlag KG, Rüdigerstraße 14, 70469 Stuttgart, Germany
C. Bracken et al. PaperSynOpen
Development of a Continuous Photochemical Benzyne-Forming 
Process
Cormac Brackena 00-001-9353-647 
Andrei S. Batsanovb 00-002-4912-0981 
Marcus Baumann*a 00-002-6996-5893
a School of Chemistry, University College Dublin, 
Science Centre South, D04 N2E2, Dublin, Ireland
marcus.baumann@ucd.ie
b Department of Chemistry, University of Durham, 
South Road, DH1 3LE, Durham, UK
Corresponding AuthorMarcus BaumannSchool of Chemistry, University College Dublin, Science Centre South, D04 N2E2, Dublin, IrelandeMail marcus.bauman @ucd.ie
Received: 23.12.2020
Accepted after revision: 07.01.2021
Published online: 01.02.2021
DOI: 10.1055/s-0040-1706016; Art ID: so-2020-d0048-op
License terms: 
© 2021. The Author(s). This is an open access article published by Thieme under the 
terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, 
permitting copying and reproduction so long as the original work is given appropriate 
credit. Contents may not be used for commercial purposes or adapted, remixed, 
transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Abstract A continuous-flow process is presented that enables the
safe generation and derivatization of benzyne under photochemical
conditions. This is facilitated by a new high-power LED lamp emitting
light at 365 nm. The resulting flow process effectively controls the re-
lease of gaseous by-products based on an adjustable backpressure reg-
ulator and delivers a series of heterocyclic products in a short residence
time of 3 minutes. The robustness of this methodology is demonstrated
for the rapid generation of benzotriazoles, 2H-indazoles and various fu-
ran-derived adducts, facilitating the preparation of these important
heterocyclic scaffolds via a simple and readily scalable flow protocol.
Key words flow chemistry, photochemistry, benzyne, cycloadditions,
high-energy intermediates, reaction development, heterocycles
Continuous-flow chemistry is now a well-established
enabling technology that provides multiple benefits arising
from reactor miniaturization, such as improved heat and
mass transfer. This allows chemists to exploit a vast variety
of transformations that are difficult to control in batch
mode.1 The creation of fleeting high-energy intermediates
and their effective trapping is thereby a prime example that
is exploited in many organometallic transformations such
as lithiation processes.2
More recently, the development of continuous light-
driven reactions has showcased the effective implementa-
tion of flow chemistry for a variety of important photo-
chemical transformations.3 The design of different flow re-
actors thereby enables applications based on both visible
light LEDs as well as traditional UV lamps to create a multi-
tude of important chemical entities.4 In view of the indus-
trial applications, photochemical transformations are gain-
ing momentum as photons are seen as traceless and tun-
able reagents, and recent reports on the scalability of
continuous photochemical processes3c,5 including those to-
wards drugs like artemisinin6 have highlighted the poten-
tial for their exploitation.
Given the salient features of flow chemistry, a class of
important transformations that is noticeably underutilized,
concerns the generation and use of benzynes.7 While
Kobayashi’s mild method starting from ortho-TMS aryl
triflates8 is one of the most exploited strategies for access-
ing benzynes, alternatives based on diazotization and sub-
sequent fragmentation of anthranilic acid derivatives or by
ortho-lithiation of halobenzenes, have been used.9 Although
the last decades have witnessed impressive applications of
especially Kobayashi’s method, which include various stud-
ies towards heteroarynes,10 the generation and use of ben-
zynes is not a commonly exploited strategy. This may point
to the necessity for generating bespoke substrates (e.g.,
TMS-aryl triflates) that require fluoride as an activation re-
agent to trigger benzyne formation, as well as concerns re-
garding scale-up of the exothermic benzyne forming pro-
cess.
We were thus intrigued by the opportunity to develop a
continuous light-driven benzyne forming reaction that
would overcome some of these limitations. Crucially, such a
continuous approach would effectively exploit the benefits
of flow chemistry, thereby rendering a robust method to
enable and stimulate further developments in this import-
ant area of research.
Upon surveying the literature, we identified two suit-
able precursors that would render the desired benzyne spe-
cies 1 upon irradiation with UV light (Scheme 1).
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Scheme 1  Comparison of precursors for photochemical benzyne for-
mation
Phthaloyl peroxide 2 is known to be a suitable benzyne
precursor with recent exploitations demonstrating its use
towards the creation of benzotriazoles.11 Benzoic acid de-
rived triazine 3 was initially reported as a photolysis prod-
uct from nitro benzaldehyde N-acylhydrazones that would
subsequently generate benzyne.12 Whilst both species
would generate benzyne accompanied by liberation of gas-
eous by-products (CO2 and N2), we decided to exploit the
latter option as a recent report by Schnarr13 outlines the use
of milder UV-A light in combination with short reaction
times, which appeared preferable in view of broader sub-
strate scope and fast reactions.
Following the reported synthesis13 of triazine species 3
that exploits diazotization of 2-aminobenzylalcohol (4), se-
quential trapping of the diazonium intermediate with
methyl amine and acetyl chloride and final oxidation to
render the carboxylic acid, we were able to access gram
quantities of this building block (Scheme 2). Pleasingly, we
were able to increase the overall yield of 3 by ca. 20% by
modifying the isolation and purification process slightly
(see below).
Scheme 2  Synthesis of benzyne precursor 3
Despite prior studies on this structure towards forma-
tion of benzyne, we were surprised by the lack of detailed
characterization that would determine its suitability to-
wards photochemical benzyne formation. To this end, we
first recorded the UV/Vis spectrum of 3, which showed a
maximum absorbance at 288 nm extending as anticipated
as far as 370 nm (UV-A; Figure 1). This provided valuable in-
formation regarding the choice of light source in subse-
quent studies.
In addition, single crystals of 3 were obtained by slow
evaporation of a sample solution (in DCM) allowing us to
analyze its molecular structure by X-ray diffraction (Figure
2). This structure14 reveals a hydrogen bond in the solid
state between the carboxyl group and the triazene moiety,
locking the conformation of this entity. Furthermore, this
results in planarity for the entire scaffold, enabling efficient
light absorption due to extended -conjugation, which mir-
rors the information observed in the UV/Vis spectrum of 3.
Figure 2  Molecular structure of 3
We next turned our attention to the development of a
continuous-flow process that would exploit a photochemi-
cal reactor to generate the benzyne intermediate in the
presence of various trapping agents. Specifically, we felt
that flow processing would provide a superior approach, as
the gaseous by-products are released safely and steadily (fa-
cilitated by using a backpressure regulator, BPR), whilst the
uniform irradiation in combination with excellent tempera-
ture control and reaction automation are key features for
future scale-up to create gram quantities of products. Based
on our group’s prior studies exploiting continuous photo-
chemical approaches, we opted to utilize a Vapourtec E-se-
ries flow platform in combination with a tunable high-pow-
er LED (2 panels, 25–50 W each) emitting light at 365 nm.15
The LED is thereby placed at the center of a flow coil reactor
(10 mL, FEP) and the two LED panels can be operated either
separately or in combination, depending on the specific ap-
plication (see the Supporting Information for photographic
details). Temperature control is achieved by directing a
stream of chilled gas (N2 or compressed air) into the en-
cased reactor system. Upon exiting this setup, the reaction




































Figure 1  UV/Vis spectrum of benzyne precursor 3 (MeCN)
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Scheme 3  Flow reactor setup for continuous benzyne formation
As depicted in Scheme 3, the benzyne precursor 3 and
the desired reaction partner would be premixed as no reac-
tion takes place in the absence of UV-light. To replicate the
synthesis of previously reported benzotriazoles,13 which
are versatile scaffolds of biological relevance,16 we prepared
a solution of azide substrate (2 equiv) and benzyne precur-
sor 3 (1 equiv, MeCN, 0.05 M) and pumped this into the
high-power LED reactor to optimize power setting, tem-
perature, and residence time. Pleasingly, it was quickly
found that both benzyl azide and phenacetyl azide were
competent reaction partners that generated the desired
benzotriazole targets 6a and 6b within a short residence
times of 3 minutes (Scheme 4). To minimize thermal degra-
dation and potential over-irradiation, the reactor tempera-
ture was maintained at ca. 28 °C whilst limiting the LED
power to 37.5 W using only one panel of LEDs. Due to the
formation of gaseous by-products (CO2 and N2) during the
benzyne forming step, a slug-flow pattern was observed in
the tubing. Separation of these gases was achieved upon
collection of the crude product after passing a BPR (ca. 2
bar).
Scheme 4  Flow synthesis of benzotriazoles and other cycloadducts; a 
1.0 equiv of 3; b 2.0 equiv of 3.
To further exploit this continuous photochemical ben-
zyne forming process, we wished to also study a set of cy-
clic dienes as reaction partners. We thus selected cyclopen-
tadiene and various furans and subjected their solutions
with 3 (MeCN, 50 mM) to our flow process. As indicated
through initial test reactions, higher yields of the corre-
sponding cycloadducts 6c–f were achieved when using an
excess of 3 (2 equiv). As before, the use of the LED emitting
at 365 nm was key to the successful synthesis of the desired
cycloadducts and enabled fast reactions through a short
residence time of 3 minutes.
Having demonstrated proof of concept, we next wished
to evaluate our method for the synthesis of 2H-indazoles
that are frequently exploited heterocycles in medicinal
chemistry programs.17 As their conventional synthesis re-
lies on multistep routes, we felt that a flow process could
streamline this effort. Specifically, we wished to utilize syd-
nones18 as readily accessible mesoionic reaction partners
that would initially undergo a formal [3+2]-cycloaddition
with benzyne, followed by [4+2]-cycloreversion. The re-
lease of gaseous CO2 would thereby be easily accommodat-
ed within our flow process.
The synthesis of the sydnones was accomplished by fol-
lowing literature precedent,18 converting N-phenyl glycine
derivatives and proline methyl ester via N-nitrosated inter-
mediates (8) into the corresponding building blocks
(Scheme 5, see the Supporting Information for details).
Scheme 5  Synthesis of sydnones 9a–g
With a small selection of sydnones at hand, we next em-
barked on their transformation into 2H-indazoles. As be-
fore, a stock solution of benzyne precursor (3, 2 equiv, 0.1 M
MeCN) and sydnone (1 equiv) was prepared and pumped
through the photoreactor (365 nm, 37.5 W) with a resi-
dence time of 3 minutes. Pleasingly, the formation of sever-
al 2H-indazoles was achieved in isolated yields up to 82%
(Scheme 6). Whilst the proline derived sydnone (9a) and
various electron-rich aryl appendages on the sydnone pre-
cursor enabled high yields (68–82%), we noticed that elec-
tron-withdrawing substituents (e.g., 3,4-dichlorophenyl)
reduced the yield significantly.19 Furthermore, using 2,6-di-
methylphenyl-substituted sydnone, no 2H-indazole prod-
uct (10g) was observed. Whilst unexpected at first, we sur-
mise that this substitution pattern leads to twisting of both
rings, as indicated by a significant drop in the UV-absor-
bance (see the Supporting Information for details). The loss
of conjugation arising from this conformational change
thus appears to cause the observed reaction outcome.
To test the robustness and scalability of this flow pro-
cess towards the creation of 2H-indazole species, we select-
ed proline derived sydnone 9a as the substrate and pro-
cessed 760 mg through our LED flow reactor. Pleasingly, this
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(68% yield) with a throughput of 4.4 mmol/h. Furthermore,
we secured single crystals of product 10a allowing us to
verify its anticipated molecular structure by means of X-ray
diffraction (Figure 3).20
Figure 3  Molecular structure of 10a
In conclusion, we have developed a versatile flow proto-
col for the photochemical generation and concurrent trap-
ping of benzyne from a stable and readily accessible tri-
azine precursor. Crucially, the tunable high-power LED light
source21 provided for uniform irradiation at 365 nm and
rendered a variety of important drug-like heterocycles in
short residence times and in high yields. Lastly, the scalabil-
ity of this flow process has been demonstrated, enabling
and facilitating future exploitations of continuous benzyne-
based transformations.
Solvents were purchased from Sigma–Aldrich and used without fur-
ther purification. Substrates and reagents were purchased from Alfa
Aesar, Fischer, Fluorochem or Sigma–Aldrich and used as received. 1H
NMR spectra were recorded with 400 and 600 MHz instruments and
are reported relative to residual solvent: CHCl3 ( = 7.26 ppm). 
13C
NMR spectra were recorded with the same instruments (100 and 151
MHz) and again are reported relative to CHCl3 ( = 77.16 ppm). Data
reported for 1H NMR are as follows: chemical shift (/ppm) (multi-
plicity, coupling constant (Hz), integration). Multiplicities are report-
ed as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pen-
tet, h = heptet, m = multiplet. Data for 13C{1H} NMR are reported in
terms of chemical shift (/ppm) and multiplicity (C, CH, CH2, or CH3).
COSY, HSQC and HMBC, experiments were used in the structural as-
signment. IR spectra were recorded with a Bruker Platinum spectro-
photometer (neat, ATR sampling) with the intensities of the charac-
teristic signals being reported as weak (w, <20% of the tallest signal),
medium (m, 21−70% of the tallest signal), or strong (s, >71% of the
tallest signal). High-resolution mass spectrometry (HRMS) was per-
formed using the indicated techniques with a micromass LCT orthog-
onal time-of-flight mass spectrometer with leucine-enkephalin (Tyr-
Gly-Phe-Leu) as an internal lock mass. For UV/Vis measurements, a
Shimadzu UV-1800 UV spectrophotometer was used. Melting points
were recorded with a Stuart SMP10 melting point apparatus and are
uncorrected. Continuous-flow experiments were performed with a
Vapourtec E-Series system equipped with a UV150 photoreactor in
combination with a high-power LED emitting light at 365 nm wave-
length.
Synthesis of (E)-2-(3-Acetyl-3-methyltriaz-1-en-1-yl)benzoic Acid 
(3)13
A suspension of 2-aminobenzyl alcohol (600 mg, 4.8 mmol, 1.00
equiv) in H2O (4 mL) was stirred at 0 °C. Concd HCl (2.4 mL, 29 mmol,
6.00 equiv) was added slowly, resulting in an orange solution. NaNO2
(342 mg, 4.9 mmol, 1.03 equiv) in H2O (1 mL) was subsequently add-
ed dropwise and the orange solution was stirred for a further 20 min-
utes before being added dropwise to a stirred solution of MeNH2 (40%
in H2O, 7.2 mL, 92.2 mmol, 19.2 equiv) at –25 °C. The reaction mix-
ture was extracted immediately upon complete addition of the diazo-
nium solution with EtOAc (2 × 40 mL). The organic phases were then
washed with sodium bicarbonate (40 mL), brine (40 mL) and dried
over Na2SO4. The solution was then concentrated in vacuo, providing
a red/orange oil, which was used in the next step without further pu-
rification.
CH2Cl2 (50 mL) was added to the red/orange oil and the solution
stirred at 0 °C before Huenig’s base was added (3.3 mL, 19.2 mmol, 4.0
equiv). AcCl (0.34 mL, 4.8 mmol, 1.0 equiv) was then added slowly
and the solution was stirred for 2.5 h. The reaction mixture was then
diluted with CH2Cl2 and acidified to pH 4–5 with 1 M HCl. The organic
phase was separated, washed with brine (40 mL), dried over Na2SO4,
and then concentrated to provide an orange oil that solidified to give
an orange solid that was used without further purification. The or-
ange solid was dissolved in acetone (50 mL) and stirred at room tem-
perature. KMnO4 (1.07 g, 6.78 mmol, 1.4 equiv) was added in portions
and the reaction was stirred for a further 3.5 h. Na2SO3 (sat. aq.) was
added in 2–3 mL portions until the purple color disappeared. The re-
action solution was diluted with CH2Cl2 (50 mL), and the solution was
acidified to pH 4–5 with 1 M HCl. The organic phase was then sepa-
rated before being washed with brine (40 mL) and dried over Na2SO4.
The reaction mixture was then concentrated in vacuo to provide 3 as
a light-brown solid. The solid was cooled before being triturated from
Et2O and filtered under suction to yield (E)-2-(3-acetyl-3-methyl-
triaz-1-en-1-yl)benzoic acid (616 mg, 2.8 mmol, 58 %) (3) as a dark-
yellow solid (mp 160–162 °C).
IR (neat): 2917 (w), 2734 (w), 1715 (s), 1594 (m), 1484 (m), 1464 (m),
1420 (m) cm–1.
1H NMR (CDCl3, 400 MHz):  = 8.34 (d, J = 8.0 Hz, 1 H), 7.76 (d, J = 8.0
Hz, 1 H), 7.66–7.62 (m, J = 8.0 Hz, 1 H), 7.55–7.51 (m, J = 8.0 Hz, 1 H),
3.51 (s, 3 H), 2.64 (s, 3 H).
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13C NMR (CDCl3, 101 MHz):  = 172.4 (C), 165.9 (C), 146.3 (C), 133.9
(C), 133.1 (CH), 130.0 (CH), 125.1 (CH), 116.6 (CH), 28.5 (CH3), 22.0
(CH3).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C10H12N3O3: 222.0873;
found: 222.0869.
UV/Vis (max, MeCN): 288 nm.
Crystal data: (CCDC-2051221): C10H11N3O3; monoclinic; a =
5.3717(4), b = 15.2445(12), c = 12.5898(8) Å,  = 91.091(3)°; V =
1030.8(2) Å3; Z = 4; space group P21/n; T = 120 K; R1 = 0.052.
Synthesis of 6a–b; General Procedure
(E)-2-(3-Acetyl-3-methyltriaz-1-en-1-yl)benzoic acid (0.22 mmol,
0.049 g, 1.0 equiv), and the corresponding azide substrate (0.44
mmol, 2.0 equiv) were dissolved in MeCN (9 mL, 50 mM). The homo-
geneous stock solution was then passed through the 10 mL coil (3.33
mL/min, residence time 3.0 min) of a Vapourtec E-series photoflow
reactor that housed an LED emitting at 365 nm. The temperature was
kept constant between 28–30 °C, and pressure was maintained at ca.
2 bar using a backpressure regulator. The emerging product solution
was collected in a round-bottom flask prior to being subjected to
evaporation of the solvent. All reactions were subsequently purified
by flash chromatography (EtOAc/ hexanes) to provide the desired
product.
1-Benzyl-1-benzo[1,2,3]triazole (6a)
Isolated yield: 66 mg (0.32 mmol, 73%); pale-brown solid; mp 113–
115 °C; Rf = 0.3 (25% EtOAc/hexanes).
IR (neat): 3063 (w), 3030 (w), 2990 (w), 2935 (w), 1733 (m), 1712
(m), 1496 (m), 1494 (m) cm–1.
1H NMR (CDCl3, 400 MHz):  = 8.06 (d, J = 8.0 Hz, 1 H), 7.42–7.26 (m, 8
H), 5.84 (s, 2 H).
13C NMR (CDCl3, 101 MHz):  = 146.3 (C), 134.7 (C), 132.8 (C), 128.9
(2x CH), 128.4 (CH), 127.6 (CH), 127.4 (2 × CH), 123.9 (CH), 120.0
(CH), 109.7 (CH), 52.2 (CH2).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C13H12N3: 210.1031; found:
210.1026.
2-(Benzo[1,2,3]triazol-1-yl)-1-phenylethan-1-one (6b)
Isolated yield: 21 mg (0.09 mmol, 56%); dark-yellow oil; Rf = 0.4 (40%
EtOAc/hexanes).
IR (neat): 3055 (w), 3029 (w), 2926 (w), 1644 (s), 1466 (m), 1410 (m).
1H NMR (CDCl3, 400 MHz):  = 8.12–8.05 (m, 3 H), 7.69–7.65 (m, 1 H),
7.57–7.47 (m, 3 H), 7.42–7.37 (m, 2 H), 6.10 (s, 2 H).
13C NMR (CDCl3, 101 MHz):  = 190.3 (C), 146.1 (C), 134.5 (C), 134.0
(C), 133.8 (CH), 133.5 (CH), 130.1 (CH), 129.2 (CH), 128.3 (CH), 127.8
(CH), 124.1 (CH), 120.2 (CH), 109.5 (CH), 53.9 (CH2).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C14H11NaN3O: 260.0794;
found: 260.0797.
Synthesis of 6c–f, 10a–f; General Procedure
(E)-2-(3-Acetyl-3-methyltriaz-1-en-1-yl)benzoic acid (2.0 equiv) and
the corresponding diene/sydnone substrate (1.0 equiv) were dis-
solved in MeCN (0.1 M, 0.05 M respectively). The homogeneous stock
solution was then passed through the 10 mL coil (3.33 mL/min, resi-
dence time: 3 min) of a Vapourtec E-series photoflow reactor that
housed an LED emitting at 365 nm. The temperature was kept con-
stant between 28–30 °C, and pressure was maintained using a back-
pressure regulator. The resulting product solution was collected in a
round-bottom flask prior to evaporation of the solvent. All reactions
were subsequently purified by silica gel chromatography to provide
the desired product.
1,4-Dihydro-1,4-methanonaphthalene (6c)
Isolated yield: 90 mg (0.63 mmol, 42%); colorless oil.
1H NMR (CDCl3, 400 MHz):  = 7.29–7.24 (m, 2 H), 7.07–6.96 (m, 4 H),
5.80 (s, 1 H), 2.40 (s, 3 H).
13C NMR (CDCl3, 101 MHz):  = 151.8 (2C), 142.9 (2CH), 124.2 (2CH),
121.5 (2CH), 70.1 (CH2), 50.3 (2CH).
1-Methyl-1,4-dihydro-1,4-epoxynaphthalene (6d)
Isolated yield: 31 mg (0.19 mmol, 84%); yellow oil; Rf = 0.4 (15%
(EtOAc/hexanes).
IR (neat): 3100 (w), 3058 (w), 3032 (w), 2934 (w), 1705 (s), 1744 (s),
1498 (m) cm–1.
1H NMR (CDCl3, 400 MHz):  = 7.21–7.14 (m, 2 H), 7.03–6.92 (m, 3 H),
6.76 (d, J = 8.0 Hz, 1 H), 5.62 (d, J = 4.0 Hz, 1 H), 1.92 (s, 3 H).
13C NMR (CDCl3, 101 MHz):  = 151.3 (CH), 150.5 (CH), 145.54 (CH),
144.3 (CH), 124.9 (C), 124.7 (C), 119.9 (C), 118.7 (CH), 89.3 (CH), 81.8
(CH), 15.2 (CH3).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C11H11O: 159.0804; found:
159.0805.
1-(1,4-Epoxynaphthalen-1-yl)ethan-1-one (6e)
Isolated yield: 24 mg (0.13 mmol, 57%); pale-yellow oil; Rf = 0.3 (15%
EtOAc/hexanes).
IR (neat): 3083 (w), 3061 (w), 3025 (w), 2977 (w), 1743 (s), 1710 (s)
cm–1.
1H NMR (CDCl3, 400 MHz):  = 7.29–7.24 (m, 2 H), 7.07–6.96 (m, 4 H),
5.80 (s, 1 H), 2.40 (s, 3 H).
13C NMR (CDCl3, 101 MHz):  = 205.2 (C), 148.0 (CH), 147.5 (CH),
143.4 (CH), 142.3 (CH), 125.6 (C), 125.2 (C), 120.6 (C), 119.6 (CH), 95.7
(CH), 82.3 (CH), 26.8 (CH3).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C12H11O2: 187.0754; found:
187.0753.
1-(4-Methyl-1,4-epoxynaphthalen-1-yl)ethan-1-one (6f)
Isolated yield: 32 mg (0.16 mmol, 72%); yellow oil; Rf = 0.4 (15%
EtOAc/hexanes).
IR (neat): 3085 (w), 3068 (w), 3028 (w), 2981 (w), 1748 (s), 1705 (s)
cm–1.
1H NMR (CDCl3, 400 MHz):  = 7.19 (t, J = 8.0 Hz, 2 H), 7.06–6.95 (m, 3
H), 6.77 (d, J = 8.0 Hz, 2 H), 2.39 (s, 3 H), 1.97 (s, 3 H).
13C NMR (CDCl3, 101 MHz):  = 205.5 (C), 150.5 (CH), 149.0 (CH),
145.9 (CH), 143.5 (CH), 125.5 (C), 124.9 (C), 119.1 (C), 119.0 (C), 95.1
(CH), 89.7 (CH), 26.8 (CH3), 15.1 (CH3).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C13H13O2: 201.0910; found:
201.0911.
2,3-Dihydro-1-pyrrolo[1,2]indazole (10a)18d
Isolated yield: 648 mg (4.1 mmol, 68%); off-white solid; mp 98–100
°C; Rf = 0.3 (50% CH2Cl2/EtOAc).
IR (neat): 3023 (w), 2983 (w), 2890 (w), 1746 (s), 1713 (s) cm–1.
34
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1H NMR (CDCl3, 400 MHz):  = 7.64 (d, J = 8.0 Hz, 1 H), 7.54 (d, J = 8.0
Hz, 1 H), 7.23 (t, J = 8.0 Hz, 1 H), 7.01 (t, J = 8.0 Hz, 1 H), 4.39 (t, J = 8.0
Hz, 2 H), 3.15 (t, J = 8.0 Hz, 2 H), 2.70 (app p, J = 8.0 Hz, 2 H).
13C NMR (CDCl3, 101 MHz):  = 153.7 (C), 138.8 (C), 125.6 (CH), 120.4
(CH), 119.8 (CH), 117.7 (CH), 116.2 (C), 48.9 (CH2), 25.8 (CH2), 23.0
(CH2).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C10H11N2: 159.0917; found:
159.0916.
Crystal data: (CCDC-2051222): C10H10N2; monoclinic; a = 6.6759(3), b
= 17.5344(8), c = 7.3037(3) Å,  = 108.476(2)°; V = 810.89(6) Å3; Z = 4;
space group P21/n; T = 120 K; R1 = 0.054.
2-Phenyl-2H-indazole (10b)18d
Isolated yield: 32 mg (0.17 mmol, 77%); yellow solid; 82–84 °C; Rf =
0.4 (10% EtOAc/hexanes).
IR (neat): 3130 (w), 3054 (w), 1628 (w), 1592 (m), 1518 (s), 1494 (s)
cm–1.
1H NMR (CDCl3, 400 MHz):  = 8.40 (d, J = 1.2 Hz, 1 H), 7.89 (dd, J = 8.6,
1.2 Hz, 2 H), 7.80–7.76 (m, 1 H), 7.70 (d, J = 8.6 Hz, 1 H), 7.51 (dd, J =
8.7, 7.2 Hz, 2 H), 7.41–7.36 (m, 1 H), 7.31 (ddd, J = 8.9, 6.6, 1.1 Hz, 1 H),
7.14–7.07 (m, 1 H).
13C NMR (CDCl3, 101 MHz):  = 149.8 (C), 140.5 (C), 129.6 (2CH), 127.9
(CH), 126.8 (CH), 122.8 (C), 122.5 (CH), 121.0 (2CH), 120.4 (CH), 120.4
(CH), 117.9 (CH).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C13H11N2: 195.0917; found:
195.0928.
2-(p-Tolyl)-2H-indazole (10c)18d
Isolated yield: 38 mg (0.18 mmol, 82%); yellow solid; 99–101 °C; Rf =
0.4 (10% EtOAc/hexanes).
IR (neat): 3133 (w), 3054 (w), 2915 (w), 2859 (w), 1627 (w), 1523 (s)
cm–1.
1H NMR (CDCl3, 400 MHz):  = 8.37 (s, 1 H), 7.81–7.77 (m, 3 H), 7.71
(dt, J = 8.0, 4.0 Hz, 1 H), 7.34–7.30 (m, 3 H), 7.12 (ddd, J = 8.4, 6.8, 0.8
Hz, 1 H), 2.43 (s, 3 H).
13C NMR (CDCl3, 100 MHz):  = 149.6 (C), 138.3 (C), 137.9 (C), 130.1
(2CH), 126.6 (CH), 122.7 (C), 122.3 (CH), 120.9 (2CH), 120.3 (CH),
120.3 (CH), 117.8 (CH), 21.0 (CH3).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C14H13N2: 209.1073; found:
209.1069.
2-(4-Methoxyphenyl)-2H-indazole (10d)18d
Isolated yield: 48 mg (0.23 mmol, 79%); yellow solid; mp 130–132 °C;
Rf = 0.4 (15% EtOAc/hexanes).
IR (neat): 3137 (w), 3053 (w), 3012 (m), 2837 (m), 1519 (s), 1244 (s)
cm–1.
1H NMR (CDCl3, 400 MHz):  = 8.31 (s, 1 H), 7.82–7.78 (m, 3 H), 7.70
(dt, J = 8.8, 1.2 Hz, 1 H), 7.32 (ddd, J = 8.4, 6.4, 0.8 Hz, 1 H), 7.11 (ddd,
J = 8.4, 6.4, 0.8 Hz, 1 H), 7.02 (d, J = 8.0 Hz, 2 H), 3.87 (s, 3 H).
13C NMR (CDCl3, 101 MHz):  = 159.3 (C), 149.6 (C), 134.1 (C), 126.5
(CH), 122.7 (C), 122.4 (2CH), 122.2 (CH), 120.3 (CH), 120.2 (CH), 117.8
(CH), 114.6 (2CH), 55.6 (CH3).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C14H13N2O: 225.1022; found:
225.1024.
2-(4-Isopropylphenyl)-2H-indazole (10e)
Isolated yield: 40 mg (0.17 mmol, 70%); yellow solid; mp 90–92 °C;
Rf = 0.5 (15% EtOAc/hexanes).
IR (neat): 3054 (w), 2958 (m), 2867 (w), 1628 (w), 1522 (s) cm–1.
1H NMR (CDCl3, 400 MHz):  = 8.38 (s,1 H), 7.83–7.79 (m, 3 H), 7.71
(dt, J = 8.8, 1.2 Hz, 1 H), 7.40–7.36 (m, 2 H), 7.32 (ddd, J = 8.8, 6.8, 0.8
Hz, 1 H), 7.11 (ddd, J = 8.8, 6.8, 0.8 Hz, 1 H), 2.99 (m, 1 H), 1.31 (d, J =
8.0 Hz, 6 H).
13C NMR (CDCl3, 101 MHz):  = 149.7 (C), 148.9 (C), 138.5 (C), 127.5 (2
× CH), 126.6 (CH), 122.7 (C), 122.3 (CH), 121.0 (2 × CH), 120.3 (CH),
120.3 (CH), 117.9 (CH), 33.8 (CH), 23.9 (2CH3).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C16H17N2: 237.1386; found:
237.1383.
2-(3,4-Dichlorophenyl)-2H-indazole (10f)
Isolated yield: 8 mg (0.03 mmol, 18%); white solid; mp 127–129 °C;
Rf = 0.3 (10% EtOAc/hexanes).
IR (neat): 3131 (w), 3100 (w), 3059 (w), 1629 (w), 1519 (s), 1485 (s)
cm–1.
1H NMR (CDCl3, 600 MHz):  = 8.38 (s, 1 H), 8.10 (d, J = 4.0 Hz, 1 H),
7.78–7.75 (m, 2 H), 7.70 (d, J = 4.0 Hz, 1 H), 7.60 (d, J = 4.0 Hz, 1 H),
7.34 (ddd, J = 9.6, 7.2, 1.2 Hz, 1 H), 7.13 (ddd, J = 9.6, 7.2, 1.2 Hz, 1 H).
13C NMR (CDCl3, 151 MHz):  = 150.1 (C), 139.6 (C), 133.8 (C), 131.8
(C), 131.2 (CH), 127.5 (CH), 123.1 (CH), 123.0 (C), 122.6 (CH), 120.4
(CH), 120.3 (CH), 119.6 (CH), 118.0 (CH).
HRMS (TOF-ESI+): m/z [M + H]+ calcd for C13H9Cl2N2: 263.0137;
found: 263.0139.
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